Sir, We would like to respond to the article titled "Re-emergence of positive symptoms of schizophrenia during the course of treatment with risperidone" (Bajaj et al.), that was published in the Indian Journal of Psychiatry, Vol.41/No.2/April, 1999. It was quite interesting to note that these authors had observed a re-emergence of positive symptoms in 7 patients, out of 30 patients of schizophr...

BACKGROUND This study aimed to evaluate synthetic cannabinoid (SC)-induced psychosis in terms of patient profile and clinical characteristics with reference to concurrently hospitalized schizophrenic patients. METHODS A total of 81 male patients diagnosed with psychotic disorder induced by the use of SCs (n=50; mean (standard deviation [SD]) age: 25.9 (5.5) years) or with schizophrenia (n=31,...

BACKGROUND Though electroconvulsive therapy (ECT) has been used in Nepal for last twenty years, researches regarding its use, its efficacy and other data are non-existent. AIMS The objective of this study was to know about diagnostic variability and therapeutic efficacy of the use of ECT in hospitalized patients. METHODS This is a prospective comparative study between patients who received ...

Method Ageneralpopulation sample of 7076 individualswas interviewedwith the Composite International Diagnostic Interview (CIDI) in1996 (baseline),1997 (T1) and1999 (T2).At T2, clinicians also scored the Brief Psychiatric Rating Scale (BPRS) item‘unusual thoughtcontent’. Analyses comparedhallucinatory experienceswith andwithout subjective distress at baseline for riskof delusion formation at fol...

BACKGROUND The relationship between the duration of untreated psychosis and long-term clinical outcomes remains uncertain. OBJECTIVE Prospectively assess the relationship of the duration of untreated psychosis on clinical outcomes in a sample of individuals with first-onset schizophrenia treated at the Pudong Mental Health Center from January 2007 to December 2008. METHODS Information about...

A recent meta-analysis showed that long-acting injectable (LAI) antipsychotics were not superior to oral antipsychotics for preventing relapse in patients with schizophrenia. We therefore designed a treatment strategy combining risperidone LAI and COMPASS (COMprehensive Psycho-educational Approach and Scheme Set), an original psychoeducational program supporting treatment with risperidone LAI a...